MANAGEMENT OF PATIENTS WITH SEVERE APLASTIC ANAEMIA WHO ARE REFRACTORY TO PLATELET TRANSFUSIONS USING LEUKOCYTE CONCENTRATES

EHA Library, jiali Huo, 215383

IRON OVERLOAD AND MANAGEMENT IN PATIENTS WITH DIAMOND BLACKFAN ANEMIA

EHA Library, Sule Unal, 215384

HIGHER RATE OF DYSMORPHIC FEATURES IN PATIENTS WITH DIAMOND BLACKFAN ANEMIA

EHA Library, Sule Unal, 215385

OPTIMIZING MRD RESPONSE ASSESSMENT USING HIGH-SENSITIVITY PERIPHERAL BLOOD MONITORING DURING TREATMENT WITH IBRUTINIB COMBINED WITH OBINUTUZUMAB OR VENETOCLAX IN CLL .

EHA Library, Andy C. Rawstron, 215386

DYNAMIC OF TELOMERIC PARAMETERS IN RELAPSING OR REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), AN ANALYSIS OF THE FILO ICLL001 BOMP TRIAL

EHA Library, laura bounaix, 215387

HIGH CD9 EXPRESSION IS ASSOCIATED WITH THE MYD88 L265P MUTATION AND REDUCED FAILURE-FREE SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Jennifer Brown, 215388

CERDULATINIB SYNERGISES WITH BCL-2 AND MCL-1 INHIBITORS TO INDUCE SUPERIOR CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Andrew J. Steele, 215389

SELECTIVE CHK1 INHIBITOR MU380 EXHIBITS SINGLE-AGENT ACTIVITY AGAINST CHRONIC LYMPHOCYTIC LEUKEMIA CELLS WITH TP53 MUTATIONS

EHA Library, Miroslav Boudny, 215390

PI3K INHIBITORS INHIBIT TUMOR MICROENVIRONMENT (TME) REGULATION OF PROGRAMMED DEATH-1 (PD1) AND PDL1/2 IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A POTENTIAL APPROACH TO OVERCOME TUMOR-INDUCED TOLERANCE

EHA Library, Fortunato Morabito, 215391

PEMBROLIZUMAB (PEM) ACTIVITY IN CLL IS IMMUNE TO TUMOR MICROENVIRONMENTAL (TME) STIMULI

EHA Library, Fortunato Morabito, 215392

DUAL MTOR KINASE INHIBITORS SYNERGIZE WITH IBRUTINIB TO INDUCE CLL APOPTOSIS, AND OVERCOME BCR- AND STROMAL-MEDIATED SURVIVAL ADVANTAGES CONFERRED IN THE MICROENVIRONMENT

EHA Library, Michael Moles, 215393

DEVELOPMENT OF SELECTIVE CASEIN KINASE 1 DELTA/EPSILON INHIBITORS FOR CANCER THERAPY

EHA Library, Michaela Gregorova, 215394

NEXT-GENERATION SEQUENCING AND CRISPR/CAS9 APPLICATION TO ELUCIDATE THE IMPLICATIONS OF TP53 MUTATIONS IN DEL(13Q) CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Miguel Quijada-Álamo, 215396

ENCYCLOPEDIA OF CLL SUBSETS: AN ONLINE KNOWLEDGEBASE FOR SUBSETS OF CLL CASES WITH STEREOTYPED B CELL RECEPTORS

EHA Library, Tomas Reigl, 215397

ANALYSIS OF LOCUS-SPECIFIC LINE-1 AND ALU ELEMENT DNA METHYLATION REVEALS NOVEL EARLY EPIGENETIC CHANGES IN CHRONIC LYMPHOCYTIC LEUKAEMIA

EHA Library, Timothy Barrow, 215398

ILT3/DELTEX-1/SHIP-1 AS A NOVEL INHIBITORY AXIS CONTROLLING B CELL RECEPTOR SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Anna KABANOVA, 215399

DETIN: OVERCOMING TUMOR IN NORMAL CONTAMINATION.

EHA Library, Amaro Taylor-Weiner, 215400

TRACKING THE MINOR CLONES IN OLIGOCLONAL CHRONIC LYMPHOCYTIC LEUKEMIA USING HIGH-THROUGHPUT IMMUNOPROFILING

EHA Library, Kamila Stranska, 215401

SINGLE CELL ABNORMALITIES ON CLASSIC G-BANDING ANALYSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA: A NEW DIAGNOSTIC AND BIOLOGICAL CHALLENGE?

EHA Library, Anastasia Athanasiadou, 215402

HIGHER RESPONSIVENESS OF CLL CELLS TO B-CELL RECEPTOR STIMULATION IS ASSOCIATED WITH REDUCED EXPRESSION OF INHIBITORY MOLECULES OF THE NF-ΚB PATHWAY

EHA Library, Ruud Meijers, 215403

COMPARISON OF CELLULAR AND CELL-FREE DNA FOR THE DETECTION AND MONITORING OF BTK MUTATED CLL CLONES IN PATIENTS WITH SUBSEQUENT THERAPY AFTER IBRUTINIB FAILURE

EHA Library, Wiebke Schier, 215404

NOVEL STRATEGIES OF TARGETING P53 RELATED VULNERABILITIES IN T-PLL CELLS

EHA Library, Jana von Jan, 215405

HIGH SET ALPHA TO SET BETA ISOFORM EXPRESSION IS ASSOCIATED WITH INFERIOR OUTCOMES AND DISCRIMINATES FAVORABLE RISK IN TWO INDEPENDENT CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) COHORTS

EHA Library, Danielle M. Brander, 215406

NOTCH1 MUTATIONS ARE AN INDEPENDENT PROGNOSTIC FACTOR IN IBRUTINIB- TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS

EHA Library, Giovanni DEL POETA, 215407

PROGNOSTIC IMPACT OF POSITIVE MINIMAL RESIDUAL DISEASE (MRD) BELOW THE THRESHOLD OF 0.01% IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS AFTER IMMUNOCHEMOTHERAPY: STUDY OF A DATASET FROM 3 FILO TRIALS

EHA Library, Remi Letestu, 215408

EVALUATION OF THE INCIDENCE, RISK FACTORS, AND MANAGEMENT OF HYPERTENSION IN PATIENTS RECEIVING IBRUTINIB FOR HEMATOLOGIC MALIGNANCIES

EHA Library, Farrukh Awan, 215409

EVALUATION OF THE CLL-IPI IN PREVIOUSLY UNTREATED CLL PATIENTS RECEIVING CHEMO-IMMUNOTHERAPY AS FIRST-LINE TREATMENT: ANALYSIS OF 845 CASES.

EHA Library, Massimo GENTILE, 215410

SPONTANEOUS CLINICAL REGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA: CLINICAL AND BIOLOGIC FEATURES OF 27 NEW CASES FROM THE EUROPEAN RESEARCH INITIATIVE ON CLL (ERIC) INTERNATIONAL REGISTRY

EHA Library, Ilaria Del Giudice, 215411

A PROGNOSTIC TOOL FOR THE IDENTIFICATION OF EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS AT IMMINENT RISK OF PROGRESSION

EHA Library, Lodovico Terzi di Bergamo, 215412

SURVIVAL CONTINUES TO INCREASE IN CHRONIC LYMPHOCYTIC LEUKEMIA: A POPULATION-BASED ANALYSIS AMONG 19,131 PATIENTS DIAGNOSED IN THE NETHERLANDS BETWEEN 1989 AND 2015

EHA Library, Lina van der Straten, 215413

PROGNOSTICATION AND FIRST-LINE TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA: A CONTEMPORARY, NATIONWIDE, POPULATION-BASED ANALYSIS AMONG 1,677 PATIENTS DIAGNOSED IN THE NETHERLANDS

EHA Library, Lina van der Straten, 215414

“IMMUNO-FLOW-FISH”: HIGH THROUGHPUT FLUORESCENCE IN SITU HYBRIDISATION OF PHENOTYPED CHRONIC LYMPHOCYTIC LEUKAEMIA BY IMAGING FLOW CYTOMETRY FOR CLINICAL APPLICATION

EHA Library, Wendy Erber, 215415

EXPRESSION OF ANTIGENS INVOLVED IN THE FORMATION OF AN IMMUNOLOGICAL SYNAPSE IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Yulia Davydova, 215416

IDENTIFICATION OF NEWLY DIAGNOSED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AT HIGH RISK OF INFECTION OR TREATMENT THROUGH MACHINE LEARNING ALGORITHMS

EHA Library, Carsten Niemann, 215417

HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN RELATION TO RESPONSE TO FIRSTLINE THERAPY AND SUBSEQUENT TREATMENTS – A METAANALYSIS OF HRQOL MEASURED IN PHASE III TRIALS OF THE GERMAN CLL STUDY GROUP

EHA Library, Nadine Kutsch, 215418

T-LARGE GRANULAR LYMPHOCYTIC (T-LGL) LEUKEMIA: A LONG-TERM STUDY ON 51 PATIENTS-COULD WE CONFINE THE USE OF THE TERM “LEUKEMIA”?

EHA Library, Xanthi Yiakoumis, 215419

FLOW CYTOMETRY AND PCR-BASED T-CELL CLONALITY TESTING FOR DISCRIMINATING BETWEEN REACTIVE AND NEOPLASTIC PROLIFERATION OF LARGE GRANULAR LYMPHOCYTES

EHA Library, Natalia Chernova, 215420

A US BASED SURVEY: THE EXPERIENCES AND PERSPECTIVES OF 1147 CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS

EHA Library, Brian Koffman, 215421

CHRONIC LYMPHOCYTIC LEUKEMIA IN ICELAND: A NATION-WIDE EPIDEMIOLOGY STUDY FROM 2003 TO 2016

EHA Library, Hrafn Thorvaldsson, 215422

ENRICHMENT OF ASXL1 PATHOGENIC VARIANTS AMONG PRIMARY REFRACTORY CML PATIENTS

EHA Library, Kristin Gustafsson, 215423

THE PIVOTAL ROLE OF INSULIN-LIKE GROWTH FACTOR PATHWAY AS A THERAPEUTIC TARGET IN ABL TYROSINE KINASE INHIBITOR RESISTANT LEUKEMIA CELLS

EHA Library, Seiichi Okabe, 215424

ASXL1 MUTATIONS ARE FREQUENT IN CHRONIC MYELOID LEUKEMIA PATIENTS RESISTANT TO TYROSINE KINASE INHIBITORS BUT NOT IN PATIENTS WITH OPTIMAL RESPONSE

EHA Library, Marcin Machnicki, 215425

THE UNCOVERING OF A BCR-ABL1 TYROSINE KINASE-INDEPENDENT SIGNATURE REVEALS NEW POTENTIAL THERAPEUTIC TARGETS IN CHRONIC MYELOID LEUKAEMIA STEM CELLS

EHA Library, Mhairi Copland, 215426

OPTIMAL TIME POINT FOR BCR-ABL1 KD MUTATION ANALYSIS IN CML PATIENTS; BASED ON 2013 ELN GUIDELINE

EHA Library, Young Rok Do, 215427

CLONAL SELECTION DETERMINES RESULTANT DOMINANCE OF TYROSINE KINASE INHIBITOR-RESISTANT CELLS IN CHRONIC MYELOID LEUKAEMIA

EHA Library, Benjamin Leow, 215428

WT1 ANALYSIS IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS

EHA Library, Sabrina COLUZZI, 215429

DIGITAL DROPLET PCR MAY BETTER IDENTIFY CANDIDATES FOR TREATMENT DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA REGARDLESS OF MEDIAN TREATMENT DURATION

EHA Library, Gioia colafigli, 215430

FREQUENCY OF TYPICAL AND ATYPICAL FUSION TRANSCRIPTS IN PATIENTS WITH BCR-ABL1-POSITIVE LEUKEMIAS – A SINGLE INSTITUTION STUDY

EHA Library, Gueorgui Balatzenko, 215431

PATIENT-SPECIFIC BCR-ABL1 GENOMIC FUSION ANALYSIS OF MINIMAL RESIDUAL DISEASE OF CML PATIENTS ELIGIBLE FOR TKI STOPPING SIGNIFICANTLY OUTPERFORMED MRNA DETECTION EITHER BY QPCR OR DIGITAL PCR

EHA Library, Katerina Machova Polakova, 215432

TREATMENT-FREE REMISSION AFTER SECOND-STOP OF IMATINIB THERAPY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE

EHA Library, Sukjoong Oh, 215433

TWO YEARS OF THERAPY WITH MATINIB GENERICS IN CHRONIC MYELOID LEUKEMIA; A REPORT FROM THE POLISH ADULT LEUKEMIA GROUP (PALG) IMATINIB GENERICS REGISTRY

EHA Library, Tomasz Sacha, 215434

MAINTENANCE THERAPY WITH DASATINIB ADMINISTRATED EVERY OTHER DAY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Clemence Loiseau, 215435

PONATINIB 15 MG DAILY, COMBINING EFFICACY AND TOLERABILITY. A RETROSPECTIVE SURVEY IN ITALY.

EHA Library, gianni binotto, 215436

THE EUTOS LONG-TERM SURVIVAL SCORE PREDICTS RESPONSE AND SURVIVAL OF ELDERLY CHRONIC MYELOID LEUKEMIA PATIENTS BETTER THAN SOKAL SCORE

EHA Library, Fausto Castagnetti, 215437

CARDIOVASCULAR TOXICITY IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH SECOND-GENERATION TYROSINE KINASE INHIBITORS IN REAL-LIFE PRACTICE. IDENTIFICATION OF RISK FACTORS AND ROLE OF PROPHYLAXIS

EHA Library, Giovanni Caocci, 215438

ULTRA-SENSITIVE DETECTION OF TYROSINE KINASE INHIBITOR RESISTANT MUTATIONS IN CHRONIC MYELOID LEUKEMIA PATIENTS USING MISEQ ILLUMINA NEXT GENERATION SEQUENCING PLATFORM

EHA Library, Marianna Romžová, 215439

PEG-INTERFERON ΑLPHA 2B CAN IMPROVE MOLECULAR RECURRENCES IN THE TREATMENT-FREE REMISSION; A PILOT STUDY WITH 18-MONTH FOLLOW-UP

EHA Library, Manuel Ayala, 215440

CROSS-INTOLERANCE WITH BOSUTINIB AFTER PRIOR TYROSINE KINASE INHIBITORS IN PATIENTS WITH PHILADELPHIA CHROMOSOME–POSITIVE LEUKEMIA: PHASE 1/2 STUDY UPDATE

EHA Library, Jorge Cortes, 215441

CHRONIC MYELOID LEUKEMIA ITALIAN MULTICENTER OBSERVATIONAL STUDY (CML-IT-MOS): ANALYSIS OF CLINICAL CHARACTERISTICS OF 1330 CML PATIENTS TREATED IN REAL-LIFE IN 66 ITALIAN CENTERS OF THE GIMEMA GROUP

EHA Library, Giorgina Specchia, 215442

IMATINIB STOP STUDY FEASIBLE TO JAPANESE CLINICAL SETTING.

EHA Library, Kensuke Usuki, 215443

THE TARGET UK STUDY: AN EVALUATION OF TYROSINE KINASE INHIBITOR RESPONSE MONITORING PATTERNS AND REAL-WORLD MOLECULAR RESPONSE RATES IN UK PATIENTS WITH CHRONIC MYELOID LEUKAEMIA

EHA Library, Adam Mead, 215444

THE OCCURRENCE AND SURVIVAL OF COLD AGGLUTININ DISEASE IN DENMARK

EHA Library, Sigbjørn Berentsen, 215445

DENSITY, HETEROGENEITY AND DEFORMABILITY OF RED CELLS AS MARKERS OF CLINICAL SEVERITY IN HEREDITARY SPHEROCYTOSIS

EHA Library, Richard van Wijk, 215446

LONG-TERM TREATMENT RESPONSE BASED ON SEVERITY OF GAUCHER DISEASE TYPE 1 AT BASELINE IN TREATMENT-NAÏVE ADULT PATIENTS AFTER 8 YEARS OF TREATMENT WITH ORAL ELIGLUSTAT

EHA Library, Elena Lukina, 215448

COMBINED EMA-BINDING TEST AND OSMOTIC GRADIANT EKTACYTOMETRY SIGNIFICANTLY IMPROVE THE LABORATORY DIAGNOSIS OF HEREDITARY SPHEROCYTOSIS

EHA Library, Andreas Glenthøj, 215449

PREVALENCE AND PREDICTORS OF LIVER FIBROSIS EVALUATED BY VIBRATION CONTROLLED TRANSIENT ELASTOGRAPHY (FIBROSCAN®) IN ADULT PATIENTS WITH TYPE 1 GAUCHER DISEASE

EHA Library, Maria Domenica Cappellini, 215450

PREVALENCE AND CLINICAL SIGNIFICANCE OF SMALL PNH CLONES IN PATIENTS WITH PRIMARY AUTOIMMUNE HEMOLYTIC ANEMIA

EHA Library, Bruno Fattizzo, 215451

COMBINATION TREATMENT OF RITUXIMAB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE FOR WARM AUTOIMMUNE HEMOLYTIC ANEMIA

EHA Library, Caroline Piatek, 215452

THE ESTABLISHMENT OF SD RAT MODEL AND HISTOPATHOLOGICAL STUDY OF IMMUNE HEMOLYTIC DISEASE INDUCED BY ANTIBODY.

EHA Library, sai yan, 215453

ALPS AND GAUCHER DISEASE. A CLINICAL AND IMMUNOLOGICAL OVERLAP

EHA Library, Maurizio Miano, 215454

ORGAN INVOLVEMENT IN RARE HEREDITARY HEMOLYTIC ANEMIA

EHA Library, Stephanie van Straaten, 215455

SUCCESSFUL TREATMENT OF MEGALOBLASTIC ANEMIA WITH BONE MARROW MYELODYSPLASIA IN LESCH-NYHAN SYNDROME

EHA Library, Maciej Machaczka, 215456

CORD BLOOD DERIVED GAMMA-DELTA T CELLS CAN BE EXPONENTIALLY EXPANDED IN VITRO TO INDUCE POTENT CYTOTOXICITY AGAINST HUMAN ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Alice Cheung, 215457

SYNERGISTIC ANTITUMORAL EFFICACY OF A NOVEL REPLICATIVE ADENOVIRUS SG611-PDCD5 AND DAUNORUBICIN IN HUMAN LEUKEMIC CELLS

EHA Library, Ya-Lan Zhou, 215458

NOVEL RNA CONSTRUCT INCREASES PERFORIN AND GRANZYME B IN NATURAL KILLER AND CYTOTOXIC T CELLS

EHA Library, Arnika Wagner, 215459

THE REDUCTION OF GRAFT-VERSUS-HOST DISEASE AND TRANSFUSIONAL NEEDS AFTER THE APPLICATION OF MESENCHYMAL STEM CELL THERAPY FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Hajnalka Andrikovics, 215460

IMMUNOGENICITY OF TISAGENLECLEUCEL IN RELAPSED/ REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) AND DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS

EHA Library, Theodore Laetsch, 215461

CONSIDERATIONS FOR TISAGENLECLEUCEL DOSING RATIONALE

EHA Library, Rakesh Awasthi, 215462

MTL-CEBPA, A SMALL ACTIVATING RNA FOR INTRAVENOUS ADMINISTRATION TO ENHANCE C/EBPΑ EXPRESSION IN PATIENTS WITH LIVER CANCER SHOWS POTENTIAL USE IN NEUTROPENIA

EHA Library, Choon Tan, 215463

SIGNIFICANT ARI-0001 (A3B1:CD8:4-1BB:CD3Z CAR19) CELL EXPANSION IN A PATIENT WITH REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PRE-LYMPHOAPHERESIS IBRUTINIB ADMINISTRATION.

EHA Library, Valentín Ortiz-Maldonado, 215464

HIGH BASELINE FERRITIN IS ASSOCIATED WITH GRADE 2 CRS REQUIRING TOCILIZUMAB OR GRADE ≥ 3 CRS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH BB2121 ANTI-BCMA CAR T CELLS

EHA Library, Jesus Berdeja, 215465

THE COMBINATION OF CD19/BCMA-DIRECTED CART CELLS INDUCED THERAPEUTIC RESPONSE AND REVERSIBLE COMPARTMENTAL CYTOKINE RELEASE SYNDROME CONFINED TO CEREBRAL REGION IN A PATIENT WITH CNS MULTIPLE MYELOMA

EHA Library, Caixia Li, 215466

INITIAL EXPERIENCE IN US COMMERCIAL MANUFACTURING OF TISAGENLECLEUCEL, A CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL THERAPY FOR PEDIATRIC RELAPSED/REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Brian Majors, 215467

ALLOGENEIC NK CELLS AND THEIR USE IN CLINICAL TRIALS

EHA Library, Ludovit Bielik, 215468

IMMUNO-T, A MOTION COMIC EDUCATING PATIENTS AND CAREGIVERS ON HOW IMMUNOTHERAPY WORKS.

EHA Library, Tessa Kerre, 215469

PERTURBATION OF FETAL LIVER STROMAL CELL FUNCTION BY TRISOMY 21 PROMOTES INCREASED ERYTHRO-MEGAKARYOPOIESIS BY FETAL HSPC

EHA Library, Natalina Elliott, 215470

PROTEIN KINASE CK2 AS A NEW PLAYER IN GATA-1 REGULATION DURING ERYTHROPOIESIS

EHA Library, Laura Quotti Tubi, 215471

TRANSCRIPTION FACTORS REGULATE DNA METHYLATION DYNAMICS IN HEMATOPOIETIC DEVELOPMENT

EHA Library, Takahiro Suzuki, 215472

CANONICAL NOTCH SIGNALING IS DISPENSIBLE FOR ADULT STEADY-STATE AND STRESS MYELO-ERYTHROPOIESIS

EHA Library, Sara Duarte, 215473

ENHANCING BONE MARROW TREPHINE BIOPSY ANALYZES: DEFINING PEDIATRIC LYMPHOID SUBPOPULATION REFEERENCE RANGES BY AUTOMATED ENUMERATION

EHA Library, Jacques Malherbe, 215474

ROLE OF SPHINGOLIPID SIGNALING IN HEMATOPOIETIC STEM AND PROGENITOR CELL MOBILIZATION

EHA Library, Alexander Carpinteiro, 215475

TELOMERASE TRANSCRIPTS FLOATING IN CANCER-DERIVED EXOSOMES REPROGRAM THE MICRORNA TRANSCRIPTOME PROFILE OF THE RECIPIENT CELLS

EHA Library, Daniela Likonen, 215476

ALTERATIONS IN STROMAL PRECURSOR CELLS IN THE BONE MARROW OF PATIENTS WITH LEUKEMIA IN THE ONSET OF THE DISEASE AND AFTER TREATMENT

EHA Library, Nataliya Petinati, 215477

LYMPHOPENIA AND RISK OF INFECTIONS AND INFECTION-RELATED DEATH IN DENMARK, 2003-2013: A PROSPECTIVE COHORT STUDY OF 98,344 INDIVIDUALS FROM THE GENERAL POPULATION

EHA Library, Marie Warny, 215478

HEMATOPOIETIC EFFECTS OF A COMPOUND: SXN AGAINST MYELOSUPPRESSION

EHA Library, Fuling Zhou, 215479

IMPACT OF SPLENECTOMY ON CD34+ BLOOD COUNT

EHA Library, Irina Galtseva, 215480

VERY LATE RELAPSES (VLRS) IN HODGKIN LYMPHOMA (HL) OCCURING ≥5 YEARS AFTER INITIAL TREATMENT WITH CHEMOTHERAPY ± RADIOTHERAPY (CT±RT): PATTERN OF RISK OVER 35 YEARS AND THE SIGNIFICANCE OF HISTOLOGY

EHA Library, Theodoros Vassilakopoulos, 215481

BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY FOR STAGE III OR IV HODGKIN LYMPHOMA: IMPACT OF CYCLE 2 PET RESULT ON MODIFIED PROGRESSION-FREE SURVIVAL

EHA Library, Robert Chen, 215482

BENDAMUSTINE IN COMBINATION WITH NIVOLUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA AFTER FAILURE OR SUBOPTIMAL RESPONSES TO NIVOLUMAB THERAPY.

EHA Library, Lepik Kirill, 215483

NIVOLUMAB RESTORES SENSITIVITY TO CHEMOTHERAPY IN CHEMOREFRACTORY CLASSICAL HODGKIN LYMPHOMA PATIENTS

EHA Library, Carmelo Carlo-Stella, 215484